Great Lakes Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,279
Closed -$560K 688
2022
Q3
$560K Sell
2,279
-284
-11% -$76.7K 0.01% 477
2022
Q2
$634K Buy
2,563
+116
+5% +$31.3K 0.01% 481
2022
Q1
$811K Sell
2,447
-7,851
-76% -$2.42M 0.01% 470
2021
Q4
$3.7M Sell
10,298
-74
-0.7% -$25K 0.06% 304
2021
Q3
$3.38M Buy
10,372
+124
+1% +$42K 0.05% 311
2021
Q2
$3.2M Sell
10,248
-9,443
-48% -$2.9M 0.05% 328
2021
Q1
$6.28M Buy
19,691
+4,144
+27% +$1.33M 0.1% 236
2020
Q4
$5.04M Sell
15,547
-302
-2% -$83.5K 0.09% 250
2020
Q3
$4.39M Buy
15,849
+699
+5% +$201K 0.09% 246
2020
Q2
$3.66M Buy
15,150
+3,334
+28% +$669K 0.09% 244
2020
Q1
$1.72M Buy
11,816
+9,950
+533% +$1.65M 0.05% 317
2019
Q4
$318K Buy
+1,866
New +$346K 0.01% 492

Other funds holding ABMD

Great Lakes Advisors's ABMD Position: Q4 2022 in Review

Great Lakes Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,279 shares — an estimated $560K sold.

Great Lakes Advisors first reported a position in ABMD in Q4 2019 and held it in 12 quarters. The position peaked at $6.28M in Q1 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Great Lakes Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Great Lakes Advisors sold 2,279 Abiomed Inc shares in Q4 2022, an estimated $560K.
  • Great Lakes Advisors first reported a position in Abiomed Inc in Q4 2019 and held it in 12 quarters.
  • Great Lakes Advisors's Abiomed Inc position peaked at $6.28M in Q1 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Great Lakes Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.